AS
Therapeutic Areas
Neurogene Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NGN-401 | Rett Syndrome | Phase 1/2 |
Leadership Team at Neurogene
RM
Rachel McMinn, Ph.D.
Founder and Chief Executive Officer
CM
Christine Mikail, J.D.
President and Chief Financial Officer
SC
Stuart Cobb, Ph.D.
Chief Scientific Officer
JJ
Julie Jordan, M.D.
Chief Medical Officer
AM
Andrew Mulberg, M.D.
Senior Vice President, Regulatory Affairs, Quality Assurance, and Quality Control
RJ
Ricardo Jimenez
Senior Vice President, Technical Operations
DM
Donna M. Cochener, J.D., LL.M.
Senior Vice President and General Counsel
RB
Robert Baffi, Ph.D.
Venture Partner (Board of Directors)
CF
Cory Freedland, Ph.D.
Partner (Board of Directors)
KW
Keith Woods
Chief Operating Officer (Board of Directors)